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Background: The neoaortoiliac system (NAIS) has gained popularity as a durable procedure for treating aortic graft
infections. However, one of the disadvantages has been a long operation that can take up to 10 hours. The goal of this
study was to assess the feasibility of staging the NAIS procedure with deep vein harvest a day before the aortofemoral
bypass and evaluate if staging had any effect on graft patency or morbidity and mortality, or both.
Methods: We reviewed data for all the NAIS procedures performed for aortic graft infections at a tertiary care university
hospital. The femoral popliteal veins of patients undergoing the staged NAIS were harvested a day in advance and left in
situ. The next day patients underwent the prosthetic graft excision with reconstruction using the femoral popliteal veins.
Patients with aortic occlusion on presentation were not candidates for vein harvest in advance and underwent a unilateral
bypass with a subsequent femorofemoral bypass as a second stage.
Results: In the last 8 years, 26 patients (17 men, 9 women; mean age, 62.6  8.3 years) underwent the NAIS procedure
for aortic graft infections. Mean follow-up was 15.7 months. Primary assisted graft patency was 100%. There were 11
patients in the staged group and 10 patients in the nonstaged group. All the staged patients underwent vein mobilization
a day before excision of aortic prosthesis. Despite undergoing a separate procedure for vein harvesting at a different time,
there was no difference in total operative time (12.0  1.8 vs 11.9  2.2 hours), operative blood loss (2.6  1.2 vs
3.4  2.4 L), and requirements for transfusion for blood products (6.7  3.7 vs 6.0  5.4 U) or crystalloid (11.3  3.1
vs 10.9  2.4 L) between the staged group and nonstaged groups. One amputation occurred in each group. The
perioperative mortality was 18% for the staged group and 20% for nonstaged group. The 12-month survival was 72% for
staged and 70% for nonstaged NAIS. No graft-related complications were observed from the preoperative vein harvest.
Conclusion:TheNAIS can be staged without compromising the efficacy of the procedure as evident by excellent long-term
patency and control of the infection. By reducing the duration of the primary procedure, stagingmay be beneficial to both
the patient and the surgeon. (J Vasc Surg 2008;48:1125-31.)Since the first description by Clagett et al1,2 in 1993,
the neoaortoiliac system (NAIS) has proven to be an effec-
tive option in the treatment of aortic graft infections.
Compared with cadaveric allografts or Rifampin-soaked
synthetic grafts, autogenous deep vein reconstruction has
been shown to be highly resistant to reinfection and asso-
ciated with excellent long-term patency.3-7 Contrary to
initial concerns, removal of the deep femoral veins has not
been associated with significant venous morbidity.8-10
One of the main drawbacks of the NAIS is the shear
magnitude of the operation in a typical elderly, malnour-
ished, and septic patient. The duration and complexity of the
procedure may be physiologically demanding for both the
patient and the surgical team. Surgeon fatigue may be associ-
atedwith errors of both judgment and technique.11,12Clagett
has emphasized the benefit of using a two-team approach to
complete the entire NAIS procedure: harvest the deep
From the Division of Vascular Surgery, The University of Arkansas for
Medical Sciences.
Competition of interest: none.
Presented at the Thirty-second Annual Meeting of the Southern Association
for Vascular Surgery, Naples, Fla, Jan 16-19, 2008.
Reprint requests: Ahsan T. Ali, MD, FACS, Division of Vascular Surgery,
University of Arkansas for Medical Sciences, 4301 W Markham St, No.
520, Little Rock, AR 72205 (e-mail: aali@uams.edu).
CME article
0741-5214/$34.00
Copyright © 2008 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2008.06.067veins, obtain vascular control in a hostile abdomen, excise
the infected graft, repair associated bowel injuries, and then
perform complex revascularization.
During the past few years, we have increasingly elected to
stage theNAISprocedure bydividing it into segments that are
less traumatic for the patient and less strenuous for the
surgical team. We conducted the present study to assess the
outcomes of patients treated with a conventional NAIS
compared with the staged NAIS procedure.
METHODS
A prospectively maintained database was queried for all
patients treated surgically for aortic graft infections from
January 1999 to November 2007 at The University of
Arkansas for Medical Sciences. Patients undergoing proce-
dures other than NAIS reconstruction with deep femoral
veins were excluded. Medical records were reviewed for
demographics, clinical presentation, and associated comor-
bidities. A noninvasive vascular laboratory evaluation in-
cluded segmental arterial pressures with ankle-brachial in-
dex (ABI) for all patients. Duplex ultrasound (DUS)
evaluation was also performed to assess the quality and
diameter of the deep femoral and popliteal veins.
The runoff score was determined according to the
reporting standards on chronic ischemia published by the
Society for Vascular Surgery.13 The diagnosis of graft in-
fection was based on the clinical presentation, supporting
laboratory values, and evaluation of a variety of imaging tech-
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angiography (CTA), DUS, and radionuclide scanning.
Conventional NAIS. The technique has been previ-
ously described by D’Addio and Clagett.14,15 Under gen-
eral anesthesia, the patient is prepared and draped from the
nipples to the feet. A longitudinal incision along the course of
the sartorius muscle is used to expose an appropriate length of
deep femoral and popliteal veins. The side branches are
divided and suture-ligated. Care is taken to preserve the
profunda femoris vein to reduce the incidence of postoper-
ative venous hypertension.
The aortic graft is then exposed through either a trans-
abdominal or retroperitoneal approach and excised. Com-
plete débridement of the aorta and the surrounding tissue is
performed. A sufficient length of deep vein is harvested.
Reconstruction of the aortofemoral segment is accom-
plished by either creating a bifurcated pantaloon graft or by
a unilateral aortofemoral graft combined with an iliofemo-
ral crossover graft.
Staged NAIS. By definition, we have used the term
staged-NAIS to refer to any aortoiliofemoral reconstruc-
tion using deep femoral popliteal veins in the treatment of
aortic graft infection that was not completed in a single
operative procedure. The decision to perform a staged
procedure was at the discretion of the attending surgeon
according to the unique anatomic and clinical features of
each patient.
At the initial operation, the deep femoral veins were
exposed, the branches divided and suture-ligated, and the
incisions temporarily closed over closed suction drains. The
femoral veins were left in situ, and flowwas not interrupted.
Overnight, sequential compression devices were used in
addition to routine deep vein thrombosis prophylaxis with
0.5 mg/kg of low-molecular-weight heparin.
The next day the infected aortic graft was excised and
the aortic reconstruction undertaken. In selected patients
with graft occlusion and ischemia, the NAIS was staged by
performing unilateral revascularization of the most isch-
emic leg, followed by revascularization of the contralateral
limb at a later date. Thus, the most symptomatic side was
revascularized with autogenous deep vein. For the con-
tralateral limb, subtotal graft excision was performed and
the distal anastomosis at the femoral level was not revised.
Subsequently, the contralateral side was revascularized with
deep vein as a femorofemoral bypass at a later date. In one
patient, we did revascularize the contralateral limb at the
time of the initial aortounifemoral NAIS with a rifampin-
soaked synthetic graft to undergo a planned subsequent
removal. All such patients undergoing a hemi-NAIS at a
given time were analyzed separately.
To classify the procedure, all patients who underwent
preoperative vein harvest were group I, all conventional
single-stage NAIS procedures were group II, and patients
with graft thrombosis who had unilateral deep vein bypass
at one time were group III. The comparison was under-
taken between patients who underwent staging by preop-
erative vein harvest (group I) and those who had a conven-
tional NAIS (group II).Operative data included American Society of Anesthe-
siology (ASA) class, total operative time, intravenous crys-
talloid volume, lowest recorded temperature, and transfu-
sion requirements. Adjunctive surgical procedures were
recorded. Postoperative data included hospital course, con-
sisting of length of stay, complications, and mortality.
Graft surveillance with DUS imaging was performed
every 3 months during the first year and every 6 months
thereafter. If indicated, contrast imaging was obtained us-
ing a CTA. Primary and secondary patency and limb salvage
data were defined according to the reporting standards for
the Society for Vascular Surgery.13 Graft failure was defined
as an occluded graft or reinfection requiring removal of the
graft.
Statistical analysis was performed using SAS software
(SAS Institute Inc, Cary, NC). Data were reported as
mean  standard deviation. Means were compared using
the Fisher exact and Cochran-Mantel-Hansel tests. A
Kaplan-Meier method was used to estimate graft patency
and patient survival.
RESULTS
During an 8-year period, 26 NAIS procedures were
performed for infrarenal aortic graft infections. Two pa-
tients were lost to long-term follow-up. Patients with iso-
lated femoral reconstruction and thoracic NAIS were not
included in this analysis. There were 11 patients who under-
went a staged NAIS (group I) and 10 who had a standard,
nonstaged NAIS (group-II). Five patients had unilateral re-
vascularization at a given time, followed by a femorofemoral
bypass with deep vein at a later stage (group III).
Demographics. The mean patient age was 62.6 8.3
years (range, 44-78 years). There were 17 men and nine
women. Twenty patients had undergone a previous aorto-
femoral bypass graft, and four patients had an infected
aortic tube or aortoiliac graft. One patient with an occluded
aortofemoral bypass graft had an infected axillofemoral
graft on the contralateral limb. One patient had an infected
endograft. Another patient presented with a failed axil-
lofemoral graft, which had been placed to treat a previous
aortic graft infection. Of the 26 patients, occlusive disease
was present in 17 (65%), eight (30%) had aneurysmal
disease, and one patient had both. In three patients the
original graft was placed for ruptured abdominal aortic
aneurysm repair. Mean ASA class was 3.7  0.5 for the
nonstaged group and 4.0 1.0 for the staged group, which
was not significantly different.
Presentation. The most common presentation was
ischemia, which occurred in 10 (38%) patients (Table I).
This included the four patients who had presented with
graft thrombosis and underwent unilateral NAIS as the
initial stage. The fifth patient in that group had undergone
an aortoiliac bypass for a ruptured aneurysm. One limb had
been occluded, and he had a femorofemoral bypass. His
initial presentation was proximal anastomotic bleeding with
pending graft disruption. He underwent an urgent aortou-
niiliac bypass with deep vein, and 1 week later, the femo-
rofemoral bypass was replaced with deep vein.
e tota
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presented with chronic ischemia. In group II (nonstaged),
two patients had acute ischemia and three had chronically
occluded grafts. Aortoenteric erosion/fistula (AEE/F) was
present in five of the 26 patients (19%). In the nonstaged
group, 4 patients had AEF. One of these patients had
disruption of the proximal anastomosis and underwent an
aortic graft replacement with Dacron graft soaked in ri-
fampin. This was followed by a staged NAIS. In the other
two patients, the AEF was graft erosion with abscess and
was found intraoperatively. Another patient in the non-
staged group had graft enteric erosion from the endograft,
which was also discovered intraoperatively. Constitutional
symptoms, including fever, malaise, and weight loss, were
present in 10 of the 26 patients (38%) on admission. Seven
patients presented with chronic groin wounds or sinuses
Table I. Presentation
Presentation Staged (n  11)
Ischemia, No. (%) 1 (9)
Acute 0
Chronic 1
ABI, mean  SD
Pre-op, right 0.92  0.1
Pre-op, left 0.85  0.3
AE fistula/erosion, No. (%) 3 (27)
Acute bleeding, No. (%) 1 (9)
Sepsis/abscess, No. (%) 3 (27)
Constitutional symptoms, No. (%) 4 (36)
Chronic groin sinuses 3 (27)
AE, Aortoenteric; NAIS, neoaortoiliac system.
Table II. Operative details and complications
Variable Staged (n  11)
Operative data, mean  SD
Operative blood loss, L 2.4  1.6
NAIS duration, h 9.1  2.6
Vein harvest duration, h 2.2  0.8
Total time, h 12.0  2.1
Secondary procedures, No.
Gastrostomy 4
Tracheostomy 2
Distal bypass/revasc 1
Colectomy 1
Fasciotomy 1
Mesh closure of abdomen 5
Operations, mean No. 3.9  1.1
Complications, No.
Renal failure 2
Post-op bleeding 1
Respiratory failure 2
Bowel obstruction/ileus 1
MOSF 0
Myocardial infarction 0
Amputation 1
Post-op sepsis 4
Reinfection 1
MSOF, Multisystem organ failure; NAIS, neoaortoiliac system.
aFive patients in group III (hemi-NAIS system) have been excluded from thwith exposed grafts (Table I).Operative details. Mean SD duration of surgery was
11.3 2.0 hours for the 10 nonstaged NAIS procedures and
9.2 1.7 hours for the 11 stagedNAIS procedures. The time
to harvest vein in the staged groupwas 2.2 0.8 hours. Thus,
the total operative time was not significantly different in
staged vs nonstaged NAIS (Table II, Fig 1).
Blood loss was not significantly different in either
group, with 2.5  1.2 L for staged vs 3.5  2.4 L for
nonstaged (P  .3; Fig 1). No anesthesia-related compli-
cations were observed in the staged group during the
harvest of the vein graft. The total cumulative crystalloid
transfused during the vein harvest and the NAIS the next
day was not statistically different from nonstaged group
(Fig 1).
Secondary procedures in addition to the NAIS were
required in 15 of the 26 patients (57%). Some procedures
aged (n  10) Hemi-NAIS (n  5) Total (n  26)
5 (50) 4 (80) 10 (38)
2 2 4 (15)
3 2 6 (23)
.48  0.4 0.43  0.4
.45  0.4 0.45  0.4
2 (20) 0 5 (19)
1 (10) 1 (20) 3 (11.5)
2 (20) 0 5 (19)
3 (30) 2 (40) 9 (35)
1 (10) 2 (40) 6 (23)
Nonstaged (n  10) Total (n  21)a
3.5  2.4 3.0  1.7
11.9  1.5 10.4  2.1
N/A . . .
11.9  1.5 . . .
5 9
1 3
1 2
0 1
4 5
4 9
3.7  2.9 . . .
2 4
2 3
1 3
1 2
2 2
1 1
1 2
0 4
2 3
l.Nonst
0
0were performed at the time of aortic graft excision and
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of procedures during the entire hospitalization: 3.9  1.1
for staged compared with 3.7  2.9 for nonstaged.
Two patients incurred limb loss, one in each group.
One patient in the staged group presented with septic
emboli to the extremity. Despite revascularization, the limb
could not be salvaged. A femoral anastomotic disruption
occurred in one patient in the nonstaged group that re-
quired ligation and eventually led to amputation.
Outcome
Mortality and survival. The mortality rate, procedur-
ally related or 30 days, was 18% (2 of 11) in the staged
group and 20% (2 of 10) in the nonstaged group. Mortality
for the entire group was 15% (4 of 26). There was no
statistical difference between the two groups when mortal-
ity was compared. No patients in group III (hemi-NAIS)
died in the perioperative period.
Complications. The over all fasciotomy rate was 34%
(9 of 26). The fasciotomy rate was 9% (1of 11) in the staged
group, 40% (4 of 10) in the nonstaged group, and 80% (4 of
5) in the hemi-NAIS group. Because all four patients
presented with severe ischemia from graft thrombosis, we
attributed this to ischemia–reperfusion. Two of the four
patients with occluded graft presented with acute ischemia.
One patient in the staged group had an outflow obstruction
of the left iliac vein that led to compartment syndrome at
the end of the NAIS procedure, requiring fasciotomy. Four
patients in the nonstaged group had fasciotomy, and all of
them presented with acute or chronic ischemia. One had a
concurrent ipsilateral great saphenous vein harvested for a
femoropopliteal bypass and a compartment syndrome de-
veloped subsequently.
Other than fasciotomy, acute renal failure was the most
Fig 1. No significant difference was found in estimated blood loss
(EBL) in liters, lowest recorded temperature in centigrade (Temp),
intravenous crystalloid (Cryst) requirement in liters, number of
packed red blood cell (RBC) units transfused, and the total dura-
tion of surgery in hours, including vein harvest time, between the
staged group (striped bars) and nonstaged group (black bars).
Error bars show the standard deviation.common postoperative complication, at 15.3% for the en-tire group. No patients required long-term dialysis. All
complications are listed in Table II.
Mean length of stay (LOS) was 27  18 days for the
staged patients and 24 12 days for the nonstaged group,
which was not statistically different.
Graft patency. Assisted primary patency after 12
months was 100% for both groups. One patient in the
nonstaged group required an angioplasty in one of the vein
grafts 2 years after the NAIS. One patient in the staged
group required an aortic stent in the native aorta above the
vein graft due to an intimal flap. This was discovered on a
CT scan shortly after the initial NAIS.
Survival. Survival at 12months was 72% for the staged
NAIS and 70% for nonstaged NAIS, with no difference on
log-rank analysis (Fig 2).
Microbiology. The most common organism species
were gram-positive (52%), followed by fungal (32%) and
gram-negative (24%). Most infections were polymicrobial
(40%), whereas only a single organism grew in 32%. No
organism was isolated in 28% of the patients.
DISCUSSION
Fundamentals of treatment regarding aortic graft infec-
tions include eradication of infection by excision of the
graft, restoration of vascular continuity, and improving the
overall state of the patient by augmenting immunity and
nutrition. Patients who present with an aortic graft infec-
tion are generally nutritionally depleted and immunologi-
cally compromised: They have been prescribed multiple
antibiotic therapies and harbor highly resistant organisms.
The first NAIS was performed 16 years ago, and the
Numbers at Risk 
Time 0 3 6 9 12 15 18 
Staged 11 10 9 7 7 6 4 
Non-staged 10 8 8 7 7 7 7 
Fig 2. Kaplan-Meier survival curve for patients undergoing
staged (green line) and nonstaged (black line) neoaortoiliac system
(NAIS), The SE was 10 after 2 months. No difference in
perioperative or 12-month survival was observed between the two
groups.series was reported as a novel treatment for aortic graft
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procedure with a very low reinfection or reintervention
rate. The NAIS procedure is technically quite demanding,
however, and aortic graft excision with an aortobifemoral
bypass using both deep veins is a laborious operation.
Because of the high complexity and the duration of the
operation, it has not been widely adopted other than in a
few selected tertiary centers. This article presents a single-
center experience of staging the NAIS by preoperative
harvest of the deep vein by surgeon’s choice.
Harvest of the deep vein is a critical part of the NAIS
operation and has to be done properly, with meticulous
attention to details. Even in the most experienced hands it
has led to unfortunate incidences of graft-related hemor-
rhage from a popped tie.16 Thus, it is paramount that the
vein harvest is done in a safe and unhurried manner. The
vein harvest can take anywhere from 2 to 3 hours, or even
longer when performed by a surgeon not familiar with the
procedure. This time is added to the front end of the
operation. Clagett et al14 have recommended using a two-
team approach, which is dependent on personnel availabil-
ity and familiarity with the NAIS.
Reilly et al17 in 1987 demonstrated that staging the extra-
anatomicbypass improvedoutcomes andwas physiologically less
stressful for thepatient. In their seriesof101patients, stagingand
sequencing was physiologically beneficial.17
The surgeon in our series tried to stage the NAIS into
several segments instead of performing an enormous oper-
ation all at once. Patient selection was at the discretion of
the surgeon. One of the methods in patients without signs
of ischemia or overt sepsis was preoperative vein mobiliza-
tion. In this series, the vein harvest a day in advance of the
aortic graft excision did not seem to cause any ill effects. We
would like to point out a few minor technical variations
from the original technique described by Clagett et al.14,18
In addition to mobilization of the veins a day in advance,
when possible, we tried to use the reversed configuration
with the femoral popliteal vein graft. Thus, in these cases,
the valvulotomy was not performed by eversion of the vein
graft. Instead, a single pass of a disposable valvulotome was
made, and the vein was then used in a reversed fashion.
Another significant differencewas the duration of postop-
erative antibiotic therapy. In pan-infected grafts or with in-
volvement of fungal organisms, we resorted to perioperative
organism-specific antibiotic therapy for 3 to 4 weeks, or even
longer, until the patient was nutritionally improved and in a
positive nitrogen balance (prealbumin16 mg/dL).
The fasciotomy rate for the entire series was 34% (9 of
26). Modrall et al19 have described the predictors of fas-
ciotomy and the increased use of crystalloid as one of the
factors. It is conceivable that an operation of shorter dura-
tion with decreased blood loss would require less total
crystalloid. However, we do not think that there was any
difference between the two groups.
Surgeon fatigue is often underestimated and seldom re-
ported. It is a reality, however, and technical errors could be
directly related to surgeon fatigue. We have shown that stag-
ing saves at least 2 to 2.5 hours from the procedure for aorticgraft excision. It is also important to note that NAIS is not
usually limited to just an aortofemoral bypass only, but often
requires adjunctive procedures. We would like to emphasize
that vein harvest one day in advance of a NAIS can only be
done in patients with a patent graft. In patients with aortic
occlusion, we have revascularized one limb at a time.
We believe that in limb-threatening ischemia, mobiliza-
tion of the femoral popliteal vein can lead to disruption of the
collaterals and precipitate acute ischemia. In the four patients
with ischemic symptoms andgraft occlusion, the aortofemoral
bypass was performed first. This was done even in the face of
low-grade infection or rest pain in the contralateral limb.
Femorofemoral bypass with vein was done 4 to 18 days later.
These patients have been reported separately.
The mortality of the nonstaged group was 20%. The
mortality for the stagedgroupwas 18%.Therewere three graft
disruptions; one patient survived the disruption where the
femoral anastomosis was ligated and underwent subsequent
above the knee amputation. This was despite a gracilis muscle
flap procedure. This patient had methicillin-resistant Staphy-
lococcus aureus graft infection. The other two patients had
proximal disruption, and they did not survive. One of the
patients had polymicrobial infections with Klebsiella pneu-
moniae and Candida species. The second patient also had a
polymicrobial infection involving Bacteroides fragilis and
Candida. We attribute this to recurrent infection. Because of
a small sample size, it did not reach statistical significance.
In summary, dealing with aortic graft infection has
evolved considerably during the last 5 years at our institu-
tion. Every attempt is made to stage the treatment when
feasible. The protocol to deal with aortic graft infection is
Fig 3. Protocol for treatment of aortic graft infections (AGI).
Fem-fem; femorofemoral bypass; FPV, femoral popliteal vein;
NAIS, neoaortoiliac system; OR, operating room.presented in Fig 3.
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domized, and this was a retrospective review. The numbers
are small, and staging was at the discretion of the operating
surgeon.
CONCLUSION
We believe that staging the NAIS is feasible, with no
added complications or untoward graft-related issues. Al-
though harvest of femoral popliteal vein graft at a separate
procedure does add another procedure, these patients un-
dergo multiple procedures as seen with patients in the
nonstaged group. Furthermore, we believe that staging
may help reduce surgeon fatigue.We therefore recommend
staging whenever possible, especially if the surgeon is not
very familiar with the NAIS.
We would like to thank Melanie Goodell for statistical
support and help with the manuscript.
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Dr Thomas Naslund (Nashville, Tenn). The authors have
addressed an important negative feature of the NAIS [neoaortoiliac
system]: that being the operation is lengthy and tedious. They have
devised a staged procedure without altering the basic operative prin-
ciples. In this report, the desired result was reached in that lengthy
operative time was avoided and outcomes were not changed. Fas-
ciotomy rate is noted to be lowerwith the staged approach, butwe are
not informed of the relative incidence of prior saphenous vein harvest
in the two groups. This risk factor as well as evolving judgment in
performing fasciotomy could explain this observation.
In general, if safety is equivalent, one operation is better than
two. Furthermore, the overall efficiency of the operating room is
diminished by this staged approach consuming more operatingroom resources by creating two separate procedures. I have three
questions:
First, was there a sentinel case that resulted in the change to
utilize a staged approach? Second, have you considered an institu-
tional cost analysis? And third, have you considered cold preserva-
tion of the deep veins to allow excision and thigh closure at the first
operation and not subject the thighs to added surgery with the
second stage?
Dr Ahsan T. Ali. In regards to the first question, there was no
sentinel case. We had a patient, we had some information on him,
and he was scheduled for a NAIS on a Wednesday. The idea came
to us to harvest his veins and mobilize them on Tuesday that will
save 2 or 3 hours. I would like to emphasize that harvest of the vein
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should be done a nonhurried manner.
Toanswer the secondquestion; I completely agree. I think it ismore
costly. It involvesa secondanesthesia,but theseareverycomplexpatients.
There is no simple solution. I think the hospital regards this as a very
specializedprocedure that Idon’t think there is apattern to thesepatients.Lastly, we did consider having vein completely harvested a day
before and placed in a preservation solution and just closing the
incisions permanently, but if you come up short by a centimeter or
two, you are going to be kicking yourself, that why didn’t I take the
appropriate length. I guess you can take extra length, but we have
not done that.
